Targeted Therapy in Biliary Tract Cancers - Test2 - elhamkhani - TriplyDB

Targeted Therapy in Biliary Tract Cancers

Targeted Therapy in Biliary Tract Cancers

http://www.wikidata.org/entity/Q26798443

about

Molecular profiling of biliary tract cancer: a target rich disease Efficacy and safety of chemotherapy with or without targeted therapy in biliary tract cancer: A meta-analysis of 7 randomized controlled trials.Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing.Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma.Intrahepatic cholangiocarcinoma: current perspectives.Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer.Immunotherapeutic Approaches to Biliary Cancer.HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis.

P2860

Q28072275-CEFD4866-0C15-414F-B4AF-5431F0E11B8E Q33440859-D051B27C-B1CA-4CD9-BC2C-8B4DEDC85297 Q36870198-E2D1E8AC-46F4-4D5A-BEB1-C6A13D2A7A60 Q37566921-A10A0939-254C-4B31-902D-40F420B30127 Q37669928-C6B8ADA4-073F-40E7-85B1-2DD2E40FCBEC Q38701620-47062824-9121-4740-B52E-32C3E3BD8A88 Q38703148-22EE8FBC-2038-4F21-9358-C01B7C05729E Q39040859-BF5C4C31-F52F-4897-9AA1-BF5F938B974B Q50127508-EEB3DFD5-22B5-4234-BA85-F31D34EB901C Q55248371-5AAF3297-90C1-4ED8-9F90-D6E0272AF6A2

P2860

Targeted Therapy in Biliary Tract Cancers

http://www.wikidata.org/entity/Q26798443

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Targeted Therapy in Biliary Tract Cancers

@ast

Targeted Therapy in Biliary Tract Cancers

@en

Targeted Therapy in Biliary Tract Cancers

@nl

type

label

Targeted Therapy in Biliary Tract Cancers

@ast

Targeted Therapy in Biliary Tract Cancers

@en

Targeted Therapy in Biliary Tract Cancers

@nl

prefLabel

Targeted Therapy in Biliary Tract Cancers

@ast

Targeted Therapy in Biliary Tract Cancers

@en

Targeted Therapy in Biliary Tract Cancers

@nl

P1433

Q26798443-3CAE647E-106B-4672-B473-2C8D13AE8BC1

P1476

Q26798443-DA8DF9A8-3773-4BB6-85B1-F7B1293D7085

P2093

Q26798443-0067BCE7-5EC2-4144-BDDD-756117A59E64

Q26798443-3CCA41DA-5D56-4075-B776-5B44E45F88E4

Q26798443-BAF138C2-A60A-4B96-9AD1-578B0EDAFB08

P275

Q26798443-7C7CDBD6-76C5-4A7B-A47E-4DB2CCE4544F

P2860

Q26798443-0172B684-7080-4754-9171-DCF5B0290446

Q26798443-0233B800-9854-4C73-AB86-B12CE6A0D051

Q26798443-05A7F776-A9B0-4A3A-944D-BECD6AF358DA

Q26798443-0684C734-A7FC-4DBD-951C-2644BB22BB3A

Q26798443-0851D51B-305B-43DB-82A2-4FF8EEBC1CB7

Q26798443-0FC38AD7-8D17-462C-9FDA-8880B767CC21

Q26798443-0FF068C9-D116-4C3F-A3A1-0F971A01266B

Q26798443-1834D7A2-9274-4157-BBEC-45EC263C3EA4

Q26798443-19970075-2CF6-4652-B25E-4498FD4A5131

Q26798443-1B0454B8-AF5A-4979-BFF3-DBF18C50EA71

P2888

Q26798443-69338353-759C-4740-B607-A28815DEA799

P304

Q26798443-5F824D42-31B0-477E-AF00-DC5E4705DA44

P31

Q26798443-877226EB-0A94-458B-BD1D-026368245FF1

Q26798443-F15C31EA-91AC-42C2-BA03-7567E57952E2

P3181

Q26798443-6789CAAC-AC35-48A1-A654-EE76681319DA

P356

Q26798443-F02B93C0-B769-4D08-8CB8-0C0C44E65923

P407

Q26798443-EF78F6F5-56C0-419A-BD98-A5C053034C0C

P433

Q26798443-071B5FB0-7CB1-466C-BAF9-9C7869F97637

P478

Q26798443-30153355-F740-4782-AA76-50DA75F22A41

P5008

Q26798443-9094D448-913C-4736-BBB1-57A93831579E

P577

Q26798443-2AC2EC2D-D2BA-4780-957D-2CB0B93EA856

Q26798443-9DEEDB60-2A73-4826-8B3A-EFE229B046A4

P5875

Q26798443-2A52FE2B-FA64-4BF8-9566-09AB6623123A

P6179

Q26798443-DFB41466-5956-4EF7-B2E0-710C1F9AF5F5

P698

Q26798443-603D4045-79C0-49DE-A6EC-82D7F6DEC405

P921

Q26798443-73A52073-F5D3-4957-B834-D7294A0F63DF

P932

Q26798443-44F0938E-C238-4B0F-8026-15B12AD4802D

P3181

P356

S11864-015-0366-0

P1433

Current Treatment Options in Oncology

P1476

Targeted Therapy in Biliary Tract Cancers

@en

P2093

Amartej Merla

http://www.w3.org/2001/XMLSchema#string

Kenneth G Liu

http://www.w3.org/2001/XMLSchema#string

Lakshmi Rajdev

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

The Cancer Genome Atlas Pan-Cancer analysis project

Obesity and the risk of gallbladder cancer: a meta-analysis

Sorafenib: a review of its use in advanced hepatocellular carcinoma

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer

The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas

Role of HER2/neu in tumor progression and therapy

Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation

BRAF mutation predicts sensitivity to MEK inhibition

Hedgehog: functions and mechanisms

The RAF proteins take centre stage

P2888

s11864-015-0366-0

P304

48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2131129

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11864-015-0366-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281058236

http://www.w3.org/2001/XMLSchema#string

P6179

1045614365

http://www.w3.org/2001/XMLSchema#string

P698

26266637

http://www.w3.org/2001/XMLSchema#string

P921

biliary tract neoplasm

P932

4534500

http://www.w3.org/2001/XMLSchema#string